Aguilera, Y.; Mellado-Damas, N.; Olmedo-Moreno, L.; López, V.; Panadero-Morón, C.; Benito, M.; Guerrero-Cázares, H.; Márquez-Vega, C.; MartÃn-Montalvo, A.; Capilla-González, V.
Preclinical Safety Evaluation of Intranasally Delivered Human Mesenchymal Stem Cells in Juvenile Mice. Cancers 2021, 13, 1169.
https://doi.org/10.3390/cancers13051169
AMA Style
Aguilera Y, Mellado-Damas N, Olmedo-Moreno L, López V, Panadero-Morón C, Benito M, Guerrero-Cázares H, Márquez-Vega C, MartÃn-Montalvo A, Capilla-González V.
Preclinical Safety Evaluation of Intranasally Delivered Human Mesenchymal Stem Cells in Juvenile Mice. Cancers. 2021; 13(5):1169.
https://doi.org/10.3390/cancers13051169
Chicago/Turabian Style
Aguilera, Yolanda, Nuria Mellado-Damas, Laura Olmedo-Moreno, VÃctor López, Concepción Panadero-Morón, Marina Benito, Hugo Guerrero-Cázares, Catalina Márquez-Vega, Alejandro MartÃn-Montalvo, and Vivian Capilla-González.
2021. "Preclinical Safety Evaluation of Intranasally Delivered Human Mesenchymal Stem Cells in Juvenile Mice" Cancers 13, no. 5: 1169.
https://doi.org/10.3390/cancers13051169
APA Style
Aguilera, Y., Mellado-Damas, N., Olmedo-Moreno, L., López, V., Panadero-Morón, C., Benito, M., Guerrero-Cázares, H., Márquez-Vega, C., MartÃn-Montalvo, A., & Capilla-González, V.
(2021). Preclinical Safety Evaluation of Intranasally Delivered Human Mesenchymal Stem Cells in Juvenile Mice. Cancers, 13(5), 1169.
https://doi.org/10.3390/cancers13051169